References
- Reid FM, Vernham GA, Jacobs FIT A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness. Hum Mutat 1994;3:243–7.
- Fischel-Ghodsian N, Prezant TR, Fournier P, et al. Mito-chondrial mutation associated with nonsyndromic deafness. Am J Otolaryngol 1995;16:403–8.
- Sevior KB, Hatamochi A, Stewart IA, et al. Mitochondrial A7445G mutation in two pedigrees with palmoplantar keratoderma and deafness. Am J Med Genet 1998;75:179–85.
- Mattiazzi M, Vijayvergiya C, Gajewski CD, et al. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by anti-oxidants. Hum Mol Genet 2004;13:869–79.
- Usami S, Abe S, Akita J, et al. Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet 2000;37:38–40.
- Bresolin N, Doriguzzi C, Ponzetto C, et al. Ubidecarenone in the treatment of mitochondrial myopathies: a multicenter double-blind trial. J Neurol Sci 1990;100:70–8.
- Seki A, Nishino I, Goto Y, et al. Mitochondrial encephalo-pathy with 15915 mutation: clinical report. Pediatr Neurol 1997;17:161–4.
- Suzuki S, Hinokio Y, Ohtomo M, et al. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 1998;41:584–8.